Interval cytoreduction in ovarian cancer.
Cannistra
S A
SA
D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000601:surgery*; D016019:Survival Analysis